United States · Markets & Finance · Yahoo Finance

Connect Biopharma COPD Study Shows 81% Cut in Treatment Failures

Published by Yahoo Finance · United States 11 h ago

Connect Biopharma (NASDAQ:CNTB) reported top-line results from its Seabreeze STAT Phase II study of rademikibart in patients experiencing acute exacerbations of chronic…

Read the full article on Yahoo Finance Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (finance.yahoo.com)

Also worth reading

Business Insider

My 16-year-old still has a 9 p.m. bedtime. It's great for our whole family.

Benzinga

Artificial Intelligence Stocks Under $10

Fortune

‘A Republic, if you can keep it’: We served presidents from both parties and have never been so concerned about election security

Cointelegraph

El Salvador receives $138 million from IMF after Bitcoin waivers granted

CNBC

Berkshire buys more Lennar shares, but pace of purchases slows

Quartz